Financial Results Galore: Complementary Research on Accuracy Inc., Teradyne, Nektar, Century Aluminum and Newpark Resources

NEW YORK, May 7, 2015 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom. 

Moments ago, Analysts Review released new research updates concerning several important developing situations including Accuracy Incorporated (NASDAQ: ARAY), Teradyne Inc. (NYSE: TER), Nektar Therapeutics (NASDAQ: NKTR), Century Aluminum Co. (NASDAQ: CENX), and Newpark Resources Inc. (NYSE: NR). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.    

To access our full PDF reports on a complementary basis, please visit the links below.


Today's update concerns the following companies:


Full PDF Download Links (you may have to copy and paste the following links into your browser):

ARAY Research Report: ( ),

TER Research Report: ( ),

NKTR Research Report: ( ),

CENX Research Report: ( ),

NR Research Report: ( ).



Analyst Update: Financial Results

U.S. stocks closed lower on Wednesday after Federal Reserve Chairwoman Janet Yellen warned investors over elevated valuations of U.S stocks and associated potential risks. The Dow Jones Industrial Average fell 0.48%, to close at 17,841.98, the S&P 500 fell 0.45%, to 2,080.15, and the NASDAQ Composite ended the session at 4,919.64, down 0.40%. Reflecting Janet Yellen's statement, European stocks saw only a modest gain on Wednesday. Germany's DAX 30 gained 0.20%, France's CAC 40 rose 0.15%, and the London's FTSE 100 closed only 0.09% higher on Wednesday. Meanwhile, Asian markets faltered again on Wednesday, depressed by weak earnings in Australia and disappointing U.S. economic data. The Shanghai Composite, Australia's S&P ASX and South Korea's KOSPI all closed lower on Wednesday.

On April 30, 2015, Accuracy Incorporated came out with its financial results for the third quarter ended March 31, 2015. The Company reported gross product orders of $51.9 million for Q3 FY 15, up 15% or $6.7 million from the previous year's third quarter.

Teradyne, Inc. reported its financial results for the first quarter of 2015 on April 30, 2015. The Company reported a revenue figure of $342 million for Q1 FY 2015. The Semiconductor Test segment was the biggest contributor, with revenues for the segment coming in at $271 million followed by the System Test and Wireless Test segments with revenues of $37 million and $34 million, respectively.

On April 30, 2015, Nektar Therapeutics reported its financial results for the first quarter of 2015. Nectar reported Q1 FY 2015 revenues of $108.8 million versus $19.8 million for Q1 FY 2014. The increase in revenue in the first quarter of 2015 is due to the recognition of $90.0 million of the $100.0 million milestone payment from AstraZeneca following the first commercial sale of Movantik in the U.S.  

On April 30, 2015 Century Aluminum Co., announced its financial results for Q1 FY 2015. Sales for the first quarter came in at $587.9 million versus $420.8 million for Q1 FY14. The shipments of primary aluminum too saw a jump during the quarter to 245,258 tonnes from 206,875 tonnes shipped in the first quarter of 2014.

Newpark Resources, Inc. announced its financial results for the first quarter of 2015 on April 30, 2015. In the course of the first quarter, the Company expanded its U.S. revolving credit facility from $125 million to $200 million, and had no borrowings outstanding under the facility as at date of announcement.


About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.


Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider, represented by a registered analyst has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit:

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review